Fecal occult blood test is the most widely used screening test for diagnosis of gastrointestinal bleeding disorders specially colorectal carcinoma. Among the various methods of fecal occult blood tests, chemical method is being used commonly, but the method has some drawbacks like low participation rate, high false positive rate, low sensitivity etc. To overcome these short comings, newer immunological method was introduced. This study evaluated the role of immunological method of fecal blood test in the diagnosis of occult lower GIT bleeding. Stool samples from two hundred patients were examined by both chemical and immunological method. The patients who were positive by any or both methods of occult blood test, were advised for colonoscopy. During colonoscopy tissues were taken for histopathology which was the gold standard of this study. Among 110 OBT positive patients pathological lesions were detected in 65 patients by colonoscopy and histopathology. The diseases detected by colonoscopy and histopathology 18 colorectal polyp, 8 colorectal cancer, 24 ulcerative lesions and 5 inflammatory bowel disease etc. Regarding comparative analysis of chemical and immunological method, the higher sensitivity (95.4% vs. 49.2%), specificity (44.4% vs. 37.8%), accuracy (74.5% vs. 44.5%), PPV (71.3% vs. 53.3%) and NPV (87% vs. 34%) of immunological method than chemical method was observed. Thus immunological method of fecal occult blood test was appeared to be a better alternative to conventional chemical method of fecal occult blood test in the diagnosis of occult lower GIT bleeding.
Introduction
Gastro intestinal bleeding disorders specially colorectal diseases are major public health issue worldwide. Occult gastrointestinal bleeding is the most common form of gastrointestinal bleeding and generally presents as iron deficiency anemia or presence of occult blood in stool 1 . The diseases causing occult blood in stools include intestinal polyps (>1cm), diverticular bleeding, ischemic colitis, anal fissure, internal hemorrhoids, infections such as amoebiasis, ascariasis, hookworm, tuberculosis, colon cancer, lymphoma, inflammatory bowel diseases etc 2 . Among these conditions, colorectal cancer is the most important because of high incidence and mortality rate 3 . The methods commonly used to diagnose GIT bleeding disorders are colonoscopy, flexible sigmoidoscopy, CT colonography and virtual colonoscopy, barium enema, fecal occult blood test and detection of human DNA in stool 4 . Among these tests colonoscopy remains the gold standard for visualization, biopsy and removal of colonic polyps 5 . But it requires expertise and is expensive, carries risks and uncomfortable for the patients, some times require full anesthesia or intravenous medicine for patient's comfort 6 . The simplest and most evaluated screening methods available for detection of occult GIT bleeding is the fecal occult blood test. There are several methods for identification of occult blood in stool. Basically these are of three categories 7 . Guaiac-type test require the peroxidase like activity of the intact heam moiety. Immunological test target antigenic sequence on the globin chains of hemoglobin and finally, heme-prophyrin test are flurometric assay that include both heme and heme derived porphyrin in their measurement 8 . In most of the countries the guaiac based method is used 9 . But the test needs dietary restrictions, produce false positive and negative results, hence it has less reliability. On the other hand, immunological test require no dietary restrictions, highly sensitive and specific for human blood and single sample examination is sufficient. So far our knowledge, there is no study in Bangladesh regarding comparative study of various methods for diagnosis of lower GIT bleeding by different type of fecal occult blood test with colonoscopy and histologic evaluation. More over the prevalence of these diseases is not known to us. The aim of this study is to detect the better method of fecal occult blood test for early diagnosis of occult lower GIT bleeding by comparing the chemical and immunological method. Thus to reduce the incidence and mortality from GIT bleeding disorders by early diagnosis and further management of the patient.
Materials and Methods
This cross sectional study was carried out in the department of Clinical Pathology, BSMMU, Dhaka during the period October, 2008 to August, 2009. For this purpose a total number of 200 patients suspected to have occult bleeding were included from inpatient and out patient department of Gastroenterology and Colorectal surgery, BSMMU. Referred cases from other areas were also included. A total of 200 patients age ranging from 16 to 84 years of both sexes, with a male to female ratio of 2:1, were enrolled in the study according to inclusion criteria. Stool samples of all patients were examined by both chemical and immunological methods. According to presence / absence of occult blood in stool samples 120 cases having occult bleeding were considered as group I and 80 cases having no occult bleeding were considered as group II. The patients who were OBT positive by any one or both methods were advised for colonoscopy. As the study was to compare the effectiveness of chemical and immunological method of fecal occult blood test, Group II patients were not undergone colonoscopy. They were advised for regular follow up. Among 120 OBT positive patients, 110 patients underwent colonoscopy. Diseases detected by colonoscopy in group I patients, 18(16.4%) colorectal polyp, 24(21.8%) colonic ulcer, 8(7.3%) colorectal cancer, 5(3.5%) inflammatory bowel disease, 7(6.4%) haemorrhoids and fissure, 2(1.8%) colonic diverticulum and 1(0.9%) proctitis. Tissue was taken from these lesions and histopathological examination done.
Results
A total of 190 patients were finally included in the study, out of which 110 patients were OBT positive which was considered as group I and 80 patients who were OBT negative were considered as group II. The mean age was 36.7±14.6 (±SD) years with their age ranged from 16 to 86 years in group I and while mean age in group II was 44.8±11.9 (±SD) years with their age ranged from 22 to 78 years.
Maximum number of patients was found in age group 21-30 years in group I. Regarding the family history, it was observed that in group I, 38(34.5%) and in group II, 15(18.8%) cases had positive family history of colorectal disease. Regarding the rate of participation in Guaiac method (GFOBT) it was found that one sample was collected from all patients in both groups. Two samples were collected from 22(20.0%) and 24(30.0%) in group I and group II respectively. Three samples were collected from 5(4.5%) in group I and 2(2.5%) in group II. Patients were also evaluated by immunological method (IFOBT) and found positive 87(79.1%) cases and negative in 23(20.9%) cases in group I patients. According to the Colonoscopy findings it was observed that 45(40.9%) cases were normal, 18(16.4%) found colonic polyp, 24(21.8%) colonic ulcer, 3(2.7%) ulcerative colitis, 7(6.4%) haemorrhoid and fissure, 8(7.3%) colorectal cancer, 2(1.8%) Crohn's disease, 2(1.8%) colonic diverticulum and 1(0.9%) proctitis in group I patients. The patients suspected to have occult bleeding were evaluated by G-FOBT and then compared with colonoscopy. Out of the 110 cases 60(54.5%) cases were positive and 50(45.5%) cases were negative in G-FOBT. Among the 60 cases, which were OBT positive evaluated by G-FOBT, 32 cases were found disease positive and 28 cases were found disease negative in colonoscopy. Whereas, 33 cases were found disease positive and 17 cases were disease negative in colonoscopy among the negative cases, which were diagnosed by G-FOBT. Therefore, 65(59.1%) cases were OBT positive and 45(40.9%) cases were OBT negative in colonoscopy. The difference was not statistically significant (p>0.05). p value of 0.178 reached from chi square test and chi value was 1.81 with 1 degree of freedom. The patients were also evaluated by I-FOBT and then compared with colonoscopy. Out of the 110 cases 87(79.1%) cases were positive and 23(20.9%) cases were negative in I-FOBT. Among the 87 cases, which were positive evaluated by I-FOBT, 62 cases were found disease positive and 25 cases were found disease negative in colonoscopy. Whereas, 3 cases were found disease positive and 20 cases were disease negative in colonoscopy among the negative cases, which were diagnosed by I-FOBT. Therefore, 65(59.1%) cases were OBT positive and 45(40.9%) cases were OBT negative in colonoscopy. The difference was statistically significant (p<0.05), p value of 0.001 reached from chi square test and chi value was 25.51 with 1 degree of freedom.
In the present study we found the higher sensitivity of IFOBT for detection of colonic cancer, colorectal polyp and ulcerative lesions in the colon, 87.5%, 100% and 93.1% respectively. On the other hand the sensitivity of GFOBT for detection of colorectal cancer, colonic polyp, and ulcerative lesions were 75%, 38.9% and 51.7% respectively.
The specificity of IFOBT for detecting colorectal cancer, colonic polyp, and ulcerative lesions were 47.1%, 42.4% and 44.4% respectively. On the other hand the specificity of GFOBT for colorectal cancer, colonic polyp, and ulcerative lesions were 21.6%, 25% and 25.9% respectively.
PPV and of GFOBT were 8%, 11.7% and 25% for detection of colorectal cancer, polyps and ulcerative lesions respectively. While the PPV of IFOBT were 10%, 20.7% and 31% for detection of colorectal cancer, polyps and ulcerative lesions respectively. The NPV of GFOBT were 95.7%, 78% and 72% for detection of colorectal cancer, polyps and ulcerative lesions. On the other hand the NPV of IFOBT were 96%, 100% and 91.3% for detection of colorectal cancer, polyps and ulcerative lesions respectively. 
Discussion
This study aimed to compare the usefulness of chemical and immunological method of fecal occult blood test in the diagnosis of occult lower GIT bleeding. Result from this study showed that immunological method has high participation rate and higher validity and reliability than chemical method.
Reduction in morbidity and mortality rates from disease causing occult bleeding by FOBT screening can be enhanced by high participation levels in the community. Choice of method is one factor that may influence participation. A simplified sampling process and reduction in number of required samples are associated with increases participation 10 . This may indicate a preference for immunological method which has no dietary restrictions and are often designed to be more user friendly 11 . Three randomized control trials of chemical method of fecal occult blood test (G-FOBT) have found lower participation rate of 17%, 22% and 33% respectively 12 . We also found the lower participation rate of GFOBT than IFOBT. One stool sample was collected from all the study subjects but two stool samples were collected from forty six patients and only seven patients were convinced to give three consecutive samples. This interpretation is consistent with the literatures which concluded that patient prefer the user friendly characteristics of immunological test 13, 14 . A telephone survey found that 17% patients indicated that dietary restrictions discourage them from participation in chemical test and this proportion increased with age and was particularly related to medication restrictions.
The overall sensitivity, specificity, accuracy, PPV and NPV of IFOBT were 95.4%, 44.4%, 74.5%, 71.3% and 87% respectively. On the other hand, the overall sensitivity, specificity, accuracy, PPV and NPV of GFOBT were 49.2%, 37%, 8%, 44.5%, 53.3% & 34% respectively. In a comparative study, Ranshoff 15 found the sensitivity of IFOBT 95.9%, and specificity 59.2%, resulting in a 30% reduction of colonoscopy use. This findings is very much consistent with our findings. A multicenter prospective case control study by Lohsiriwat 16 in Thailand found the overall sensitivity, specificity, positive predictive value, and negative predictive value of IFOBT were 91.0%,93.8%, 95.8% & 87.0% respectively, which supported the present study.
In this study we also calculated individually the accuracy of GFOBT and IFOBT for detection of colonic polyp, colorectal cancer and ulcerative lesions in the colon. As the incidence of colorectal cancer is more common in western countries, the comparative study between the two methods of OBT were done to detect colorectal cancer and colonic polyps in OBT positive patients. Although in developing country, the prevalence of colorectal cancer is low (1/100,000), the incidence is increasing day by day due to change in life style, dietary habit and huge urbanization 17 . The relative risk of developing colorectal carcinoma in Bangladesh is also high 18 . In this perspective, it is necessary to screen colorectal cancer among our asymptomatic average risk population of our country to reduce it's incidence and prevalence rate. Although polyps and ulcerative lesions are benign but it is proved that in time they may progress to invasive cancers. Polyps, specially larger (>1cm) polyps become colorectal cancer at a rate of roughly 1% per year 9 . Considering this fact we had evaluated the individual performance characteristics of GFOBT and IFOBT for detection of polyp and cancer.
In the present study we found the higher sensitivity of IFOBT for detection of colonic polyp, colorectal cancer and ulcerative lesions in the colon, 87.5%, 100% and 93.1% respectively. On the other hand, the sensitivity of GFOBT for detection of colorectal cancer, colonic polyp, and ulcerative lesions were 75%, 38.9%, 51.7% respectively. These findings are nearly similar to the findings noted by Simon
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where higher sensitivity of IFOBT (75% to over 90%) than GFOBT were found. On the other hand, sensitivity of GFOBT can be achieved as high as 90% by using repeated test, rehydration and diet restriction. This study recommended that the newer generation of test such as immunological test would undoubtedly proved even better in practice. Morikawa et al. 20 also found higher sensitivity of IFOBT in a study among 21805 Japanese population. Allison et al. 9 found that the sensitivity of IFOBT for detecting the colorectal cancer was 82%, substantially higher than that of GFOBT. The estimated sensitivity of GFOBT for cancer ranged from 13% to 60% in the five economic models of colon cancer screening in average risk adults. Although there were differences in results (ranged from 66% to 98%), the sensitivity of IFOBT in many published studies was much higher than results reported for GFOBT, which suggested that the method would show improved performance over GFOBT in screening programmes 10 .
Regarding specificity, in this study we found higher specificity of IFOBT than GFOBT. The specificity of IFOBT for detecting colorectal cancer, colonic polyp, and ulcerative lesions were 47.1%, 42.4%, 44.4% respectively. On the other hand, the specificity of GFOBT for colorectal cancer, colonic polyp, and ulcerative lesions were 21.6%, 25%, 25.9% respectively. The higher specificity of IFOBT was also noted by Burch et al. 21 who reported the eight diagnostic case control studies regarding comparison of two methods. Among these 8 studies, IFOBT had higher specificities in four studies, another four studies founded comparable specificity of both methods.
In the present study we had analyzed positive and negative predictive value of GFOBT and IFOBT for detection of colorectal cancer, polyps and ulcerative lesions. It was observed that PPV and of GFOBT were 8%, 11.7% and 25%for detection of colorectal cancer, polyps and ulcerative lesions respectively. Again the PPV of IFOBT were 10%, 20.7% and 31% for detection of colorectal cancer, polyps and ulcerative lesions respectively. The NPV of GFOBT were 95.7%, 78% and 72% for detection of colorectal cancer, polyps and ulcerative lesions. On the other hand the NPV of IFOBT were 96%, 100% and 91.3% for detection of colorectal cancer, polyps and ulcerative lesions respectively. Guittet et al.
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also observed higher(8.7% vs 7.3%) PPV of IFOBT than GFOBT for detection of polyp and (49.2% vs 27.2%) for detection of colorectal neoplasia.
The potential usefulness of IFOBT compared with GFOBT was being considered by several organizations. The American Cancer Society's recommended that in comparison with guaiacbased tests for the detection of occult blood, immunological tests were more patient friendly and were likely to be equal or better in sensitivity and specificity. The World Health Organization and the World Organizaton for Digestive Endoscopy have also endorsed the use of immunological test because population cannot be relied on to comply with the dietary and drug restrictions necessary for guaiac-based tests 23 .
Evidence in favour of the use of IFOBT over the GFOBT is increasing. A number of variables may influence guaiac test results that do not influence the results of immunological tests. Because guaiac tests depend upon peroxidase or pseudoperoxidase activity in feaces not specific to human hemoglobin. So the ingestion of animal hemoglobin/ myoglobin in red meat, fruits and vegetables high in peroxidase activity, and aspirin and other medication that may produce gastrointestinal bleeding, may cause false-positive results and high dose of vitamin C and fecal dehydration which may cause false negative results. IFOBT have no dietary or medication restrictions. These tests have superior sensitivity and specificity and a higher compliance rate as suggested in recent reviews.
Limitation of the study: There were some limitations in this study. First of all who were OBT negative by initial screening were not undergone for further evaluation. But there might be any disease among these average risk patients which could be evaluated and treated as well. However these patients were advised to visit their physician regularly. Secondly, exact incidence and prevalence of colorectal carcinoma could not be find out by this study because some suspected patients of colorectal cancer presented with visible per rectal bleeding which was an exclusion criteria. Indeed, our view of this study was to find out the better method of occult blood rest which can be used in large scale screening programme. Finally, patients could not take necessary medication during three days preparatory period for fecal occult blood test.
